Literature DB >> 2919549

Intravenous dipyridamole: body weight considerations and dosage requirements.

A Camp1, B R Chaitman, H Goodgold, S Byers, L Shaw, G Barth, L Samuels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2919549     DOI： 10.1016/0002-8703(89)90754-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  An optimal dual-size vial system for the cost-effective usage of Adenoscan.

Authors:  J C Hung; D W Mahoney; D L Johnston; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

2.  Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile-SPECT.

Authors:  F M Baer; K Smolarz; P Theissen; E Voth; H Schicha; U Sechtem
Journal:  Int J Card Imaging       Date:  1993-06

3.  Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole.

Authors:  S James Cullom; James A Case; Staci A Courter; A Iain McGhie; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.